Clinical trial
Nebulized Ketamine for the Treatment of Major Depressive Disorder
NCT06752759
Study timeline
Study start (actual)2024-10-16Date precision: day
Registry last updated2026-04-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Severe Depressionunresolved
Moderate Depressionunresolved
Ketamineunresolved
Midazolamunresolved
Peripheral Nervous System Agentsunresolved
Central Nervous System Agentsunresolved
Neurotransmitter Agentsunresolved
Physiologic Effects of Drugsunresolved
Sensory System Agentsunresolved
Analgesics, Non-Narcoticunresolved
Anti-Inflammatory Agents, Non-Steroidalunresolved
Depressive Symptomunresolved
Hypnotics and Sedativesunresolved
Anti-anxiety Agentsunresolved
Tranquilizing Agentsunresolved
Psychotropic Drugsunresolved
Anesthetics Agentunresolved
Interventions
Sponsors & collaborators
Theresa Jacob, PhD, MPHlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06752759 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.